Literature DB >> 1642718

Behavior of cardiac output during progressive exercise tests: a preliminary report.

Y Miyamoto1, K Niizeki, H Abe.   

Abstract

The behavior of cardiac output (Q) during progressive incremental exercise tests was studied in young healthy men. Q approached a plateau and leveled off at almost the same work rate at which oxygen uptake (VO2) attained its maxima, while heart rate (HR) still continued to rise. This suggests that the limiting factor for maximal aerobic capacity in healthy subjects is Q. The rate of increase in Q and HR accelerated from a work rate which is close to the ventilatory anaerobic threshold (AT). The prime cause of the progressive augmentation in cardiac activity is probably an accelerated release of plasma catecholamine and/or potassium. There is a possibility that these substances might also affect the AT.

Entities:  

Mesh:

Year:  1992        PMID: 1642718     DOI: 10.2114/ahs1983.11.225

Source DB:  PubMed          Journal:  Ann Physiol Anthropol        ISSN: 0287-8429


  4 in total

1.  Circulatory "efficacy" during progressive aerobic exercise in children: insights from the Q: VO(2) relationship.

Authors:  Thomas Rowland
Journal:  Eur J Appl Physiol       Date:  2007-05-03       Impact factor: 3.078

2.  Cardiac output and oxygen uptake relationship during physical effort in men and women over 60 years old.

Authors:  Paulo T V Farinatti; Pedro P S Soares
Journal:  Eur J Appl Physiol       Date:  2009-08-27       Impact factor: 3.078

3.  Stroke volume and cardiac output during 6 minute-walk tests are strong predictors of maximal oxygen uptake in people after stroke.

Authors:  Fang Liu; Alice Y M Jones; Raymond C C Tsang; Fubing Zha; Mingchao Zhou; Kaiwen Xue; Zeyu Zhang; Yulong Wang
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

Review 4.  The Oxygen Uptake Plateau-A Critical Review of the Frequently Misunderstood Phenomenon.

Authors:  Max Niemeyer; Raphael Knaier; Ralph Beneke
Journal:  Sports Med       Date:  2021-04-29       Impact factor: 11.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.